Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+53.8%
5Y CAGR+4.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+53.8%/yr
Annual compound
5Y CAGR
+4.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $319.77M | +130.0% |
| 2024 | $139.04M | -3.4% |
| 2023 | $143.94M | +63.8% |
| 2022 | $87.88M | -41.1% |
| 2021 | $149.10M | -40.7% |
| 2020 | $251.25M | - |
| 2019 | $0.00 | - |